Insider filing · IBRX
Cheryl Cohen sold $1.2M of ImmunityBio (IBRX)
Executed Jul 2, disclosed Jul 7, 4 days later.
Value, as filed
$1.2M
131,210 sh × $9.50
Executed
Jul 2
the trade date, as filed
Disclosed
Jul 7
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CC
Cheryl Cohen
Director
profile →
Cheryl Cohen (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.2M of IBRX (131,210 sh × $9.50, as filed), executed Jul 2.
The name
IBRX
ImmunityBio, Inc.
IBRX · Healthcare · 10 filings in 24 months
ticker →
Healthcare · ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→